{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:34:13Z","timestamp":1789889653105,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00702-013-1135-5","type":"journal-article","created":{"date-parts":[[2013,12,17]],"date-time":"2013-12-17T04:47:54Z","timestamp":1387255674000},"page":"881-889","source":"Crossref","is-referenced-by-count":16,"title":["The potential role of kynurenines in Alzheimer\u2019s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors"],"prefix":"10.1007","volume":"121","author":[{"given":"Zs\u00f3fia","family":"Majl\u00e1th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Toldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"issue":"2","key":"1135_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s007020050149","volume":"106","author":"H Baran","year":"1999","unstructured":"Baran H, Jellinger K, Deecke L (1999) Kynurenine metabolism in Alzheimer\u2019s disease. J Neural Transm 106(2):165\u2013181","journal-title":"J Neural Transm"},{"issue":"6","key":"1135_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1073\/pnas.33.6.155","volume":"33","author":"GW Beadle","year":"1947","unstructured":"Beadle GW, Mitchell HK, Nyc JF (1947) Kynurenine as an intermediate in the formation of nicotinic acid from tryptophane by Neurospora. Proc Natl Acad Sci USA 33(6):155\u2013158","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1135_CR3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","volume":"55","author":"MF Beal","year":"1990","unstructured":"Beal MF, Matson WR, Swartz KJ, Gamache PH, Bird ED (1990) Kynurenine pathway measurements in Huntington\u2019s disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 55(4):1327\u20131339","journal-title":"J Neurochem"},{"issue":"1","key":"1135_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","volume":"108","author":"MF Beal","year":"1992","unstructured":"Beal MF, Matson WR, Storey E, Milbury P, Ryan EA, Ogawa T, Bird ED (1992) Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex. J Neurol Sci 108(1):80\u201387","journal-title":"J Neurol Sci"},{"issue":"2","key":"1135_CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bbr.2010.02.041","volume":"210","author":"P Carrillo-Mora","year":"2010","unstructured":"Carrillo-Mora P, Mendez-Cuesta LA, Perez-De La Cruz V, Fortoul-van Der Goes TI, Santamaria A (2010) Protective effect of systemic l-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25\u201335) in rat hippocampus. Behav Brain Res 210(2):240\u2013250","journal-title":"Behav Brain Res"},{"issue":"2","key":"1135_CR6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","volume":"18","author":"Y Chen","year":"2010","unstructured":"Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, Grant R, Brew BJ, Guillemin GJ (2010) The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res 18(2):132\u2013142","journal-title":"Neurotox Res"},{"issue":"4","key":"1135_CR7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1476-5381.1988.tb11474.x","volume":"93","author":"JH Connick","year":"1988","unstructured":"Connick JH, Stone TW (1988) Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br J Pharmacol 93(4):868\u2013876","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1135_CR8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","volume":"26","author":"LG Darlington","year":"2007","unstructured":"Darlington LG, Mackay GM, Forrest CM, Stoy N, George C, Stone TW (2007) Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26(8):2211\u20132221","journal-title":"Eur J Neurosci"},{"issue":"4","key":"1135_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0197-0186(95)00091-7","volume":"28","author":"LP Carvalho de","year":"1996","unstructured":"de Carvalho LP, Bochet P, Rossier J (1996) The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem Int 28(4):445\u2013452","journal-title":"Neurochem Int"},{"issue":"4","key":"1135_CR10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","volume":"33","author":"JC Torre de la","year":"2002","unstructured":"de la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33(4):1152\u20131162","journal-title":"Stroke"},{"key":"1135_CR11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2013.08.028","volume":"553","author":"I Demeter","year":"2013","unstructured":"Demeter I, Nagy K, Farkas T, Kis Z, Kocsis K, Knapp L, Gellert L, Fulop F, Vecsei L, Toldi J (2013) Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study. Neurosci Lett 553:138\u2013141","journal-title":"Neurosci Lett"},{"issue":"6","key":"1135_CR12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog Neurobiol 64(6):575\u2013611","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1135_CR13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-4159.2011.07414.x","volume":"119","author":"CM Forrest","year":"2011","unstructured":"Forrest CM, Mackay GM, Oxford L, Millar K, Darlington LG, Higgins MJ, Stone TW (2011) Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery. J Neurochem 119(1):136\u2013152","journal-title":"J Neurochem"},{"issue":"6","key":"1135_CR14","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood\u2013brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56(6):2007\u20132017","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"1135_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2011.05.069","volume":"667","author":"L Gellert","year":"2011","unstructured":"Gellert L, Fuzik J, Goblos A, Sarkozi K, Marosi M, Kis Z, Farkas T, Szatmari I, Fulop F, Vecsei L, Toldi J (2011) Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia. Eur J Pharmacol 667(1\u20133):182\u2013187","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1135_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00702-011-0692-8","volume":"119","author":"L Gellert","year":"2012","unstructured":"Gellert L, Varga D, Ruszka M, Toldi J, Farkas T, Szatmari I, Fulop F, Vecsei L, Kis Z (2012) Behavioural studies with a newly developed neuroprotective KYNA-amide. J Neural Transm 119(2):165\u2013172","journal-title":"J Neural Transm"},{"key":"1135_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-8-17","volume":"8","author":"AB Gold","year":"2011","unstructured":"Gold AB, Herrmann N, Swardfager W, Black SE, Aviv RI, Tennen G, Kiss A, Lanctot KL (2011) The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflammation 8:17\u201334","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1135_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","volume":"17","author":"P Guidetti","year":"2004","unstructured":"Guidetti P, Luthi-Carter RE, Augood SJ, Schwarcz R (2004) Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease. Neurobiol Dis 17(3):455\u2013461","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1135_CR19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.20432","volume":"55","author":"P Guidetti","year":"2007","unstructured":"Guidetti P, Hoffman GE, Melendez-Ferro M, Albuquerque EX, Schwarcz R (2007) Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55(1):78\u201392","journal-title":"Glia"},{"issue":"4","key":"1135_CR20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","volume":"78","author":"GJ Guillemin","year":"2001","unstructured":"Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78(4):842\u2013853","journal-title":"J Neurochem"},{"issue":"18","key":"1135_CR21","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1097\/00001756-200312190-00005","volume":"14","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smythe GA, Veas LA, Takikawa O, Brew BJ (2003) A beta 1\u201342 induces production of quinolinic acid by human macrophages and microglia. NeuroReport 14(18):2311\u20132315","journal-title":"NeuroReport"},{"issue":"4","key":"1135_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM (2005) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol Appl Neurobiol 31(4):395\u2013404","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"20","key":"1135_CR23","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000345062.86148.3f","volume":"72","author":"MD Haag","year":"2009","unstructured":"Haag MD, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH (2009) Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology 72(20):1727\u20131734","journal-title":"Neurology"},{"issue":"23\u201324","key":"1135_CR24","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1111\/j.1432-1033.2004.04446.x","volume":"271","author":"Q Han","year":"2004","unstructured":"Han Q, Li J (2004) pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem 271(23\u201324):4804\u20134814","journal-title":"Eur J Biochem"},{"key":"1135_CR25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2091-11-19","volume":"11","author":"Q Han","year":"2010","unstructured":"Han Q, Cai T, Tagle DA, Li J (2010) Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases. BMC Biochem 11:19\u201337","journal-title":"BMC Biochem"},{"issue":"2","key":"1135_CR26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuint.2006.08.012","volume":"50","author":"Z Hartai","year":"2007","unstructured":"Hartai Z, Juhasz A, Rimanoczy A, Janaky T, Donko T, Dux L, Penke B, Toth GK, Janka Z, Kalman J (2007) Decreased serum and red blood cell kynurenic acid levels in Alzheimer\u2019s disease. Neurochem Int 50(2):308\u2013313","journal-title":"Neurochem Int"},{"issue":"2","key":"1135_CR27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-3083.2009.02280.x","volume":"70","author":"P Hempel","year":"2009","unstructured":"Hempel P, Karczewski P, Kohnert KD, Raabe J, Lemke B, Kunze R, Bimmler M (2009) Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors. Scand J Immunol 70(2):159\u2013160","journal-title":"Scand J Immunol"},{"issue":"Pt 5","key":"1135_CR28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A et al (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(Pt 5):1249\u20131273","journal-title":"Brain"},{"issue":"19","key":"1135_CR29","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21(19):7463\u20137473","journal-title":"J Neurosci"},{"issue":"1","key":"1135_CR30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nbd.2009.04.009","volume":"35","author":"M Hiltunen","year":"2009","unstructured":"Hiltunen M, Makinen P, Peraniemi S, Sivenius J, van Groen T, Soininen H, Jolkkonen J (2009) Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus. Neurobiol Dis 35(1):103\u2013113","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1135_CR31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/ije\/20.3.736","volume":"20","author":"A Hofman","year":"1991","unstructured":"Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, Copeland JR, Dartigues JF, da Silva Droux A, Hagnell O et al (1991) The prevalence of dementia in Europe: a collaborative study of 1980\u20131990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 20(3):736\u2013748","journal-title":"Int J Epidemiol"},{"issue":"4\u20135","key":"1135_CR32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","volume":"105","author":"S Hoyer","year":"1998","unstructured":"Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105(4\u20135):415\u2013422","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"1135_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2004.02.049","volume":"490","author":"S Hoyer","year":"2004","unstructured":"Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490(1\u20133):115\u2013125","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1135_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5715","volume":"2","author":"C Iadecola","year":"1999","unstructured":"Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2(2):157\u2013161","journal-title":"Nat Neurosci"},{"issue":"6","key":"1135_CR35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1034\/j.1600-0404.2003.00076.x","volume":"107","author":"J Ilzecka","year":"2003","unstructured":"Ilzecka J, Kocki T, Stelmasiak Z, Turski WA (2003) Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand 107(6):412\u2013418","journal-title":"Acta Neurol Scand"},{"issue":"11","key":"1135_CR36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s002340000404","volume":"42","author":"K Ishii","year":"2000","unstructured":"Ishii K, Sasaki M, Matsui M, Sakamoto S, Yamaji S, Hayashi N, Mori T, Kitagaki H, Hirono N, Mori E (2000) A diagnostic method for suspected Alzheimer\u2019s disease using H(2)15O positron emission tomography perfusion Z score. Neuroradiology 42(11):787\u2013794","journal-title":"Neuroradiology"},{"issue":"5","key":"1135_CR37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-3083.2012.02684.x","volume":"75","author":"P Karczewski","year":"2012","unstructured":"Karczewski P, Hempel P, Kunze R, Bimmler M (2012a) Agonistic autoantibodies to the alpha(1)-adrenergic receptor and the beta(2)-adrenergic receptor in Alzheimer\u2019s and vascular dementia. Scand J Immunol 75(5):524\u2013530","journal-title":"Scand J Immunol"},{"issue":"7","key":"1135_CR38","doi-asserted-by":"crossref","first-page":"e41602","DOI":"10.1371\/journal.pone.0041602","volume":"7","author":"P Karczewski","year":"2012","unstructured":"Karczewski P, Pohlmann A, Wagenhaus B, Wisbrun N, Hempel P, Lemke B, Kunze R, Niendorf T, Bimmler M (2012b) Antibodies to the alpha1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography. PLoS One 7(7):e41602","journal-title":"PLoS One"},{"issue":"4","key":"1135_CR39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/WAD.0b013e31823dbcfc","volume":"26","author":"MJ Katz","year":"2012","unstructured":"Katz MJ, Lipton RB, Hall CB, Zimmerman ME, Sanders AE, Verghese J, Dickson DW, Derby CA (2012) Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord 26(4):335\u2013343","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"1135_CR40","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","volume":"52","author":"M Kessler","year":"1989","unstructured":"Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52(4):1319\u20131328","journal-title":"J Neurochem"},{"key":"1135_CR41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2013.02.006","volume":"70","author":"C Klein","year":"2013","unstructured":"Klein C, Patte-Mensah C, Taleb O, Bourguignon JJ, Schmitt M, Bihel F, Maitre M, Mensah-Nyagan AG (2013) The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction. Neuropharmacology 70:254\u2013260","journal-title":"Neuropharmacology"},{"issue":"1","key":"1135_CR42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2012.02.007","volume":"9","author":"MA Kling","year":"2013","unstructured":"Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE (2013) Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement 9(1):76\u201392","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1135_CR43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.neuroscience.2004.04.043","volume":"126","author":"E Knyihar-Csillik","year":"2004","unstructured":"Knyihar-Csillik E, Csillik B, Pakaski M, Krisztin-Peva B, Dobo E, Okuno E, Vecsei L (2004) Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Neuroscience 126(4):899\u2013914","journal-title":"Neuroscience"},{"issue":"1","key":"1135_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.HYP.0000132475.32317.bb","volume":"44","author":"ES Korf","year":"2004","unstructured":"Korf ES, White LR, Scheltens P, Launer LJ (2004) Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 44(1):29\u201334","journal-title":"Hypertension"},{"issue":"6 Suppl","key":"1135_CR45","first-page":"S61","volume":"6","author":"SA Lipton","year":"2004","unstructured":"Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer\u2019s disease and other neurologic disorders. J Alzheimers Dis 6(6 Suppl):S61\u2013S74","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1135_CR46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1756285613494989","volume":"6","author":"Z Majlath","year":"2013","unstructured":"Majlath Z, Tajti J, Vecsei L (2013) Kynurenines and other novel therapeutic strategies in the treatment of dementia. Ther Adv Neurol Disord 6(6):386\u2013397. doi: 10.1177\/1756285613494989","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"1135_CR47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.0022-3042.2002.00805.x","volume":"80","author":"M Marchi","year":"2002","unstructured":"Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M (2002) Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80(6):1071\u20131078","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"1135_CR48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2008.12.022","volume":"604","author":"M Marosi","year":"2009","unstructured":"Marosi M, Fuzik J, Nagy D, Rakos G, Kis Z, Vecsei L, Toldi J, Ruban-Matuzani A, Teichberg VI, Farkas T (2009) Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol 604(1\u20133):51\u201357","journal-title":"Eur J Pharmacol"},{"issue":"6\u20137","key":"1135_CR49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10571-009-9364-8","volume":"29","author":"D Nagy","year":"2009","unstructured":"Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L, Teichberg VI, Toldi J (2009) Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol 29(6\u20137):827\u2013835","journal-title":"Cell Mol Neurobiol"},{"issue":"7","key":"1135_CR50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s10571-010-9542-8","volume":"30","author":"D Nagy","year":"2010","unstructured":"Nagy D, Knapp L, Marosi M, Farkas T, Kis Z, Vecsei L, Teichberg VI, Toldi J (2010) Effects of blood glutamate scavenging on cortical evoked potentials. Cell Mol Neurobiol 30(7):1101\u20131106","journal-title":"Cell Mol Neurobiol"},{"issue":"24","key":"1135_CR51","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1016\/j.bmc.2011.10.029","volume":"19","author":"K Nagy","year":"2011","unstructured":"Nagy K, Plangar I, Tuka B, Gellert L, Varga D, Demeter I, Farkas T, Kis Z, Marosi M, Zadori D, Klivenyi P, Fulop F, Szatmari I, Vecsei L, Toldi J (2011) Synthesis and biological effects of some kynurenic acid analogs. Bioorg Med Chem 19(24):7590\u20137596","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"1135_CR52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567202054368326","volume":"2","author":"H Nemeth","year":"2005","unstructured":"Nemeth H, Toldi J, Vecsei L (2005) Role of kynurenines in the central and peripheral nervous systems. Curr Neurovasc Res 2(3):249\u2013260","journal-title":"Curr Neurovasc Res"},{"issue":"Suppl","key":"1135_CR53","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/nrn1433","volume":"10","author":"PJ Nestor","year":"2004","unstructured":"Nestor PJ, Scheltens P, Hodges JR (2004) Advances in the early detection of Alzheimer\u2019s disease. Nat Med 10(Suppl):S34\u2013S41","journal-title":"Nat Med"},{"issue":"1","key":"1135_CR54","doi-asserted-by":"crossref","first-page":"H315","DOI":"10.1152\/ajpheart.00022.2002","volume":"283","author":"K Niwa","year":"2002","unstructured":"Niwa K, Kazama K, Younkin L, Younkin SG, Carlson GA, Iadecola C (2002a) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 283(1):H315\u2013H323","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1135_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","volume":"9","author":"K Niwa","year":"2002","unstructured":"Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C (2002b) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9(1):61\u201368","journal-title":"Neurobiol Dis"},{"issue":"1\u20132","key":"1135_CR56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","volume":"451","author":"A Novelli","year":"1988","unstructured":"Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res 451(1\u20132):205\u2013212","journal-title":"Brain Res"},{"issue":"9","key":"1135_CR57","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","volume":"42","author":"T Ogawa","year":"1992","unstructured":"Ogawa T, Matson WR, Beal MF, Myers RH, Bird ED, Milbury P, Saso S (1992) Kynurenine pathway abnormalities in Parkinson\u2019s disease. Neurology 42(9):1702\u20131706","journal-title":"Neurology"},{"issue":"2","key":"1135_CR58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-8993(91)91583-M","volume":"542","author":"E Okuno","year":"1991","unstructured":"Okuno E, Nakamura M, Schwarcz R (1991) Two kynurenine aminotransferases in human brain. Brain Res 542(2):307\u2013312","journal-title":"Brain Res"},{"issue":"9","key":"1135_CR59","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53(9):1937\u20131942","journal-title":"Neurology"},{"key":"1135_CR60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1403.003","volume":"1122","author":"GF Oxenkrug","year":"2007","unstructured":"Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann NY Acad Sci 1122:35\u201349","journal-title":"Ann NY Acad Sci"},{"issue":"6","key":"1135_CR61","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1471-4159.1993.tb07437.x","volume":"61","author":"AM Palmer","year":"1993","unstructured":"Palmer AM, Marion DW, Botscheller ML, Swedlow PE, Styren SD, DeKosky ST (1993) Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem 61(6):2015\u20132024","journal-title":"J Neurochem"},{"issue":"6","key":"1135_CR62","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, Stoffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013\u2013too little activation is bad, too much is even worse. Neuropharmacology 53(6):699\u2013723","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"1135_CR63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0304-3940(92)90749-W","volume":"144","author":"SJ Pearson","year":"1992","unstructured":"Pearson SJ, Reynolds GP (1992) Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine Huntington\u2019s disease. Neurosci Lett 144(1\u20132):199\u2013201","journal-title":"Neurosci Lett"},{"issue":"4","key":"1135_CR64","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51(4):1256\u20131262","journal-title":"Diabetes"},{"issue":"1","key":"1135_CR65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","volume":"247","author":"MN Perkins","year":"1982","unstructured":"Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247(1):184\u2013187","journal-title":"Brain Res"},{"issue":"1","key":"1135_CR66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0197-4580(00)00106-8","volume":"21","author":"H Petrovitch","year":"2000","unstructured":"Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS Honolulu-Asia Aging Study. Neurobiol Aging 21(1):57\u201362","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"1135_CR67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","volume":"402","author":"C Prescott","year":"2006","unstructured":"Prescott C, Weeks AM, Staley KJ, Partin KM (2006) Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402(1\u20132):108\u2013112","journal-title":"Neurosci Lett"},{"issue":"2","key":"1135_CR68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","volume":"27","author":"WQ Qiu","year":"2006","unstructured":"Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer\u2019s disease: review and hypothesis. Neurobiol Aging 27(2):190\u2013198","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1135_CR69","doi-asserted-by":"crossref","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","volume":"4","author":"A Rahman","year":"2009","unstructured":"Rahman A, Ting K, Cullen KM, Braidy N, Brew BJ, Guillemin GJ (2009) The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One 4(7):e6344","journal-title":"PLoS One"},{"issue":"10","key":"1135_CR70","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00966592","volume":"16","author":"C Rios","year":"1991","unstructured":"Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 16(10):1139\u20131143","journal-title":"Neurochem Res"},{"issue":"8","key":"1135_CR71","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00702-008-0052-5","volume":"115","author":"E Rozsa","year":"2008","unstructured":"Rozsa E, Robotka H, Vecsei L, Toldi J (2008) The Janus-face kynurenic acid. J Neural Transm 115(8):1087\u20131091","journal-title":"J Neural Transm"},{"issue":"1","key":"1135_CR72","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051233","volume":"12","author":"A Ruitenberg","year":"2001","unstructured":"Ruitenberg A, Skoog I, Ott A, Aevarsson O, Witteman JC, Lernfelt B, van Harskamp F, Hofman A, Breteler MM (2001) Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 study. Dement Geriatr Cogn Disord 12(1):33\u201339","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1\u20132","key":"1135_CR73","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","volume":"257","author":"K Sas","year":"2007","unstructured":"Sas K, Robotka H, Toldi J, Vecsei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257(1\u20132):221\u2013239","journal-title":"J Neurol Sci"},{"key":"1135_CR74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","volume":"43","author":"DJ Selkoe","year":"2003","unstructured":"Selkoe DJ, Schenk D (2003) Alzheimer\u2019s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545\u2013584","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"1135_CR75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/HYPERTENSIONAHA.109.128744","volume":"54","author":"R Stewart","year":"2009","unstructured":"Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2009) Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 54(2):233\u2013240","journal-title":"Hypertension"},{"issue":"4","key":"1135_CR76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-6147(00)01451-6","volume":"21","author":"TW Stone","year":"2000","unstructured":"Stone TW (2000) Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci 21(4):149\u2013154","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"1135_CR77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72(4):411\u2013412","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"1135_CR78","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CE, Alves LB, Porciuncula LO, Emanuelli T, Souza DO (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40(7):621\u2013627","journal-title":"Neurochem Int"},{"issue":"4","key":"1135_CR79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1600-0404.2002.1o148.x","volume":"105","author":"AR Varma","year":"2002","unstructured":"Varma AR, Adams W, Lloyd JJ, Carson KJ, Snowden JS, Testa HJ, Jackson A, Neary D (2002) Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer\u2019s disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 105(4):261\u2013269","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1135_CR80","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L Vecsei","year":"2013","unstructured":"Vecsei L, Szalardy L, Fulop F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12(1):64\u201382","journal-title":"Nat Rev Drug Discov"},{"issue":"31","key":"1135_CR81","doi-asserted-by":"crossref","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281(31):22021\u201322028","journal-title":"J Biol Chem"},{"issue":"11","key":"1135_CR82","doi-asserted-by":"crossref","first-page":"e3742","DOI":"10.1371\/journal.pone.0003742","volume":"3","author":"K Wenzel","year":"2008","unstructured":"Wenzel K, Haase H, Wallukat G, Derer W, Bartel S, Homuth V, Herse F, Hubner N, Schulz H, Janczikowski M, Lindschau C, Schroeder C, Verlohren S, Morano I, Muller DN, Luft FC, Dietz R, Dechend R, Karczewski P (2008) Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One 3(11):e3742","journal-title":"PLoS One"},{"key":"1135_CR83","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4615-4709-9_19","volume":"467","author":"B Widner","year":"1999","unstructured":"Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D (1999) Degradation of tryptophan in neurodegenerative disorders. Adv Exp Med Biol 467:133\u2013138","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"1135_CR84","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s007020050029","volume":"107","author":"B Widner","year":"2000","unstructured":"Widner B, Leblhuber F, Walli J, Tilz GP, Demel U, Fuchs D (2000) Tryptophan degradation and immune activation in Alzheimer\u2019s disease. J Neural Transm 107(3):343\u2013353","journal-title":"J Neural Transm"},{"issue":"2","key":"1135_CR85","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","volume":"109","author":"B Widner","year":"2002","unstructured":"Widner B, Leblhuber F, Fuchs D (2002) Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease. J Neural Transm 109(2):181\u2013189","journal-title":"J Neural Transm"},{"key":"1135_CR86","first-page":"1","volume":"136","author":"H Wolf","year":"1974","unstructured":"Wolf H (1974) The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Lab Invest Suppl 136:1\u2013186","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"3","key":"1135_CR87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(00)00024-8","volume":"390","author":"HQ Wu","year":"2000","unstructured":"Wu HQ, Lee SC, Schwarcz R (2000) Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus. Eur J Pharmacol 390(3):267\u2013274","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1135_CR88","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0896-6273(00)80115-4","volume":"16","author":"BA Yankner","year":"1996","unstructured":"Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer\u2019s disease. Neuron 16(5):921\u2013932","journal-title":"Neuron"},{"key":"1135_CR89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gene.2005.09.034","volume":"365","author":"P Yu","year":"2006","unstructured":"Yu P, Li Z, Zhang L, Tagle DA, Cai T (2006) Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365:111\u2013118","journal-title":"Gene"},{"issue":"6","key":"1135_CR90","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","volume":"118","author":"D Zadori","year":"2011","unstructured":"Zadori D, Nyiri G, Szonyi A, Szatmari I, Fulop F, Toldi J, Freund TF, Vecsei L, Klivenyi P (2011) Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington\u2019s disease. J Neural Transm 118(6):865\u2013875","journal-title":"J Neural Transm"},{"issue":"1\u20132","key":"1135_CR91","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2012.06.004","volume":"322","author":"D Zadori","year":"2012","unstructured":"Zadori D, Klivenyi P, Szalardy L, Fulop F, Toldi J, Vecsei L (2012) Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders. J Neurol Sci 322(1\u20132):187\u2013191","journal-title":"J Neurol Sci"},{"issue":"6","key":"1135_CR92","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW, Louie JY, Wu T, Scearce-Levie K, Patrick C, Adame A, Giorgini F, Moussaoui S, Laue G, Rassoulpour A, Flik G, Huang Y, Muchowski JM, Masliah E, Schwarcz R, Muchowski PJ (2011) Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145(6):863\u2013874","journal-title":"Cell"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1135-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1135-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1135-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:32:08Z","timestamp":1564965128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1135-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1135-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}